Before you sell to, join or invest in C2N Diagnostics, LLC
MentionFox check on C2N Diagnostics, LLC: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/c2n-diagnostics-llc-form-d-25000001
Check C2N Diagnostics, LLC before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about C2N Diagnostics, LLC?
Based on the record MentionFox holds for this company. No flag is not a clearance.
C2N Diagnostics, LLC filed a Form D with the Securities and Exchange Commission on 2025-05-30.
C2N Diagnostics, LLC filed a Form D notice of an exempt securities offering with the SEC on May 30, 2025. The filing reports $10M sold. Its industry group is Biotechnology. It names Dr. Joel Braunstein (Executive Officer, Director), Dr. Randall Bateman (Director), Dr. Michael Goldblatt (Director) (SEC Form D, May 30, 2025).
Is this your company?
Sell to companies like C2N Diagnostics, LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns C2N Diagnostics, LLC.
Free to see. No signup.
More on the people and the money behind C2N Diagnostics, LLC, from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when C2N Diagnostics, LLC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when C2N Diagnostics, LLC raises, hires or launches. No email unless you switch it on.
Watch C2N Diagnostics, LLC →Get the full cited report on C2N Diagnostics, LLC
What the filing shows about C2N Diagnostics, LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on C2N Diagnostics, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives C2N Diagnostics, LLC's address as 4340 Duncan Avenue, St. Louis, MO 63110.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
C2N Diagnostics, LLC is a registered filer with the SEC (CIK 2021597) and has filed since 2024-05-06. 3 filings are on record, the latest on 2025-05-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
C2N Diagnostics, LLC's Form D of 2025-05-30 names Dr. Joel Braunstein, Dr. Randall Bateman, Dr. Michael Goldblatt and 3 more as its officers, directors or promoters.
Its new offerings report $17.50M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Developing and accelerating novel diagnostics and therapies for Alzheimer’s disease. C2N new PrecivityAD™ blood test for Alzheimers disease. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer disease.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Dr. Joel Braunstein is named as Executive Officer and Director on the Form D that C2N Diagnostics, LLC filed with the SEC on 30 May 2025, one of 6 people that filing names.
Dr. Randall Bateman is named as Director on the Form D that C2N Diagnostics, LLC filed with the SEC on 30 May 2025, one of 6 people that filing names.
Dr. Michael Goldblatt is named as Director on the Form D that C2N Diagnostics, LLC filed with the SEC on 30 May 2025, one of 6 people that filing names.
Dr. David Holtzman is named as Director on the Form D that C2N Diagnostics, LLC filed with the SEC on 30 May 2025, one of 6 people that filing names.
Micah Onixt is named as Executive Officer on the Form D that C2N Diagnostics, LLC filed with the SEC on 30 May 2025, one of 6 people that filing names.
Fred Miller is named as Director on the Form D that C2N Diagnostics, LLC filed with the SEC on 30 May 2025, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2025-05-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about C2N Diagnostics, LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on C2N Diagnostics, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on C2N Diagnostics, LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist C2N Diagnostics, LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind C2N Diagnostics, LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-02 (c2n.com).
Each opens in a new tab, filled in for C2N Diagnostics, LLC. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in St. Louis
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/c2n-diagnostics-llc-form-d-25000001